Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2012
06/07/2012US20120142742 Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
06/07/2012US20120142741 Pharmaceutical compositions for the treatment of cancer
06/07/2012US20120142740 Novel alkene derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142739 Novel oxadiazole derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142738 Pharmaceutical composition for treating dermatological autoimmune diseases
06/07/2012US20120142737 Pharmaceutical compositions of a non-enteric coated proton pump inhibitor with a carbonate salt and bicarbonate salt combination
06/07/2012US20120142736 Novel pyridine derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142735 Disubstituted [4-(5-aminomethyl-phenyl)-piperidin-1-yl]- 1h-indol-3-yl]-methanones
06/07/2012US20120142734 Methods for treating tumors with thalidomide
06/07/2012US20120142733 4-substituted-cyclohexylamino-4-piperidinyl-acetamide antagonists of ccr2
06/07/2012US20120142732 Heteroaryls and uses thereof
06/07/2012US20120142731 Methods of inhibiting viral infection
06/07/2012US20120142730 Use of laquinimod for reducing fatigue, improving functional status, and improving quality of life in multiple sclerosis patients
06/07/2012US20120142729 KAT ll INHIBITORS
06/07/2012US20120142728 Chemical compound and its use
06/07/2012US20120142727 Nitrogenous-ring acylguanidine derivative
06/07/2012US20120142726 Pharmaceutical compositions comprising 3,4-dihydroisoquinolin-2(1h)-yl-3-phenylurea derivatives having formyl peptide receptor like-1 (fprl-1) agonist or antagonist activity
06/07/2012US20120142725 Combined Use of an Alpha-Adrenergic Receptor Antagonist and an Anti-Muscarinic Agent
06/07/2012US20120142724 OXAZOLO[5-4-b]PYRIDIN-5-YL COMPOUNDS
06/07/2012US20120142723 Ace2 activator compounds and methods of use thereof
06/07/2012US20120142722 Conjugates of cytotoxic drugs
06/07/2012US20120142721 Small molecule inhibitors of polynucleotide kinase/phosphatase, poly(adp-ribose) polymerase and uses thereof
06/07/2012US20120142720 Phenylethanoic Acid, Phenylpropanoic Acid and Phenylpropenoic Acid Conjugates and Prodrugs of Hydrocodone, Methods of Making and Use Thereof
06/07/2012US20120142719 Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof
06/07/2012US20120142718 N-17-Alkylated Prodrugs of Opioids
06/07/2012US20120142717 Compounds
06/07/2012US20120142716 4-pyrimidinesulfamide derivative
06/07/2012US20120142715 Polymorph of [4,6-bis(dimethylamino)-2-(4-benzyl)pyrimidin-5-yl]
06/07/2012US20120142714 Bicyclic compound
06/07/2012US20120142713 Crystalline forms of 6-(1h-imidazol-1-yl)-2-phenylquinazoline
06/07/2012US20120142712 8-(3-amino-piperidin-1-yl)-xanthines, their preparation, and their use as pharmaceuticals
06/07/2012US20120142711 Acid-labile trigger units
06/07/2012US20120142710 Ketolide Compounds Having Antimicrobial Activity
06/07/2012US20120142709 Substituted pyridinone-pyridinyl compounds
06/07/2012US20120142708 Substituted pyridine urea compounds
06/07/2012US20120142707 Modified c-3 betulinic acid derivatives as hiv maturation inhibitors
06/07/2012US20120142706 Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatment
06/07/2012US20120142705 Isatin and oxindole compounds
06/07/2012US20120142704 Pharmaceutical solution of cetirizine hydrochloride
06/07/2012US20120142703 New combination therapy in treatment of oncological and fibrotic diseases
06/07/2012US20120142702 Integrin-linked kinase inhibitors
06/07/2012US20120142701 Compounds and methods for the treatment of proliferative diseases
06/07/2012US20120142699 Trazodone and trazodone hydrochloride in purified form
06/07/2012US20120142697 Salt forms of 4-(4-Methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl) pyrimidin-2-ylamino)phenyl]-benzamide
06/07/2012US20120142696 Substituted indole/indazole-pyrimidinyl compounds
06/07/2012US20120142695 Compounds as bradykinin b1 antagonists
06/07/2012US20120142694 Substituted 4-hydroxypyrimidine-5-carboxamides
06/07/2012US20120142693 Crystalline compound of 7-[(3r)-3-amino-1-oxo-4-(2, 4, 5-trifluorphenyl)butyl]-5, 6, 7, 8-tetrahydro-3-(tri fluormethyl)-1, 2, 4 -triazolo[4,3-a]pyrazin
06/07/2012US20120142692 Antifolate combinations
06/07/2012US20120142691 Picolinamide derivatives as ttx-s blockers
06/07/2012US20120142690 Substituted piperidines
06/07/2012US20120142689 Serotonin reuptake inhibitors
06/07/2012US20120142688 Preparation of 1-(substituted aryl)-5-trifluoromethyl-2-(1h)pyridone compounds and salts thereof and their applications
06/07/2012US20120142687 Indolecarboxylic acid derivative having pgd2 receptor antagonistic activity
06/07/2012US20120142686 Viral polymerase inhibitors
06/07/2012US20120142685 Organic compounds
06/07/2012US20120142684 Compounds and methods for skin repair
06/07/2012US20120142683 Pyrimidine substituted purine compounds as kinase (s) inhibitors
06/07/2012US20120142682 Antivirulence compounds inhibiting bacterial mono-adp-ribosyltransferase toxins
06/07/2012US20120142681 Heterocyclic hydrazone compounds
06/07/2012US20120142680 Heteroalkyl linked pyrimidine derivatives
06/07/2012US20120142679 Novel 2,3-dihydro-1h-imidazo(1,2-a)pyrimidin-5-one derivatives, preparation thereof, and pharmaceutical use thereof
06/07/2012US20120142678 Novel compound useful for the treatment of degenerative and inflammatory diseases
06/07/2012US20120142677 Pyrrolidine Compounds Which Modulate The CB2 Receptor
06/07/2012US20120142676 Oxathiazine and dithiine oxides as inhibitors of sulfhydryl-dependent biomolecules
06/07/2012US20120142675 Methods for Treating Diseases of the Retina
06/07/2012US20120142674 N-phenyl-(homo)piperazinyl-benzenesulfonyl or benzenesulfonamide compounds suitable for treating disorders that respond to the modulation of the serotonin 5-ht6 receptor
06/07/2012US20120142673 Pyrido-, Pyrazo- and Pyrimido-Pyrimidine Derivatives as mTOR Inhibitors
06/07/2012US20120142672 Heterocyclic compound and use thereof
06/07/2012US20120142671 Benzamides and nicotinamides as syk modulators
06/07/2012US20120142670 N-(amino-heteroaryl)-1H-pyrrolopyridine-2-carboxamides derivatives preparation thereof and their use in therapy
06/07/2012US20120142669 N-(amino-heteroaryl)-1H-pyrrolopyridine-2-carboxamides derivatives preparation thereof and their use in therapy
06/07/2012US20120142668 Cathepsin c inhibitors
06/07/2012US20120142667 Pyrimidine derivatives as zap-70 inhibitors
06/07/2012US20120142666 Azetidine 2-Carboxamide Derivatives Which Modulate The CB2 Receptor
06/07/2012US20120142665 Triazolopyridine compounds
06/07/2012US20120142664 Novel benzyl azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142663 Novel azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142662 Novel azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142661 Novel oxime azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142660 Aminopyrimidines useful as kinase inhibitors
06/07/2012US20120142659 Compounds and their use as ikach blockers
06/07/2012US20120142658 Therapeutical use of ternary complexes of valproic acid
06/07/2012US20120142657 Gaba-steroid antagonists and their use for the treatment of cns disorders
06/07/2012US20120142656 Buccal application system comprising 17a-estradiol
06/07/2012US20120142655 Novel crystal form of an organic compound and process for the preparation thereof
06/07/2012US20120142654 Prognostic marker for mamma carcinoma
06/07/2012US20120142653 C-28 amides of modified c-3 betulinic acid derivatives as hiv maturation inhibitors
06/07/2012US20120142652 Compositions and methods for localized therapy of the eye
06/07/2012US20120142651 Method of treatment of allergic rhinitis
06/07/2012US20120142650 Method for treating lung disease
06/07/2012US20120142649 Compositions and methods for delivering clonidine and bupivacaine to a target tissue site
06/07/2012US20120142648 Methods for delivering clonidine compositions in biodegradable polymer carrier and local steriods to a target tissue site
06/07/2012US20120142647 Novel Compounds as Respiratory Stimulants for Treatment of Breathing Control Disorders or Diseases
06/07/2012US20120142646 Novel Compounds 621
06/07/2012US20120142645 Neuroactive steroid compositions and methods of use for lowering cholesterol
06/07/2012US20120142644 Method for producing phytosterol/phytostanol phospholipid esters
06/07/2012US20120142643 Clonidine and gaba compounds in a biodegradable polymer carrier
06/07/2012US20120142642 Novel oxime derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142641 Targetted drug delivery to the bone
1 ... 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 ... 7860